SCHEMBL1205134

SCHEMBL1205134

NC(=S)NNc1cc2ccccc2[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 2/20 0.43
▸ MAPT P10636 8/20 0.42
▸ GAA P10253 6/20 0.42
▸ ALDH1A1 P00352 6/20 0.42
▸ KDM4E B2RXH2 2/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ EGFR P00533 1/20 0.41
▸ KDR P35968 1/20 0.41
▸ GLA P06280 1/20 0.40
▸ LOXL2 Q9Y4K0 1/20 0.40
▸ FLT3 P36888 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ ALOX12 P18054 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ DAO P14920 2/20 0.39
▸ HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4506889 0.83 AOC3 (0.46) AOC3MAPTGAAALDH1A1KDM4E
SCHEMBL3068361 0.74 GRIK1 (0.49) AOC3MAPTGAAALDH1A1KDM4E
SCHEMBL927313 0.72 AOC3 (0.46) AOC3MAPTGAAALDH1A1KDM4E
SCHEMBL5493171 0.72 KDM4E (0.51) AOC3MAPTGAAALDH1A1KDM4E
SCHEMBL3082016 0.72 GRIK1 (0.45) AOC3MAPTGAAALDH1A1KDM4E
SCHEMBL4506884 0.72 GRIK1 (0.45) AOC3MAPTGAAALDH1A1KDM4E
SCHEMBL3476327 0.72 AOC3 (0.54) AOC3MAPTGAAALDH1A1KDM4E
SCHEMBL30287355 0.72 AOC3 (0.54) AOC3MAPTGAAALDH1A1KDM4E
SCHEMBL31232953 0.72 FLT3 (0.48) AOC3MAPTGAAALDH1A1KDM4E
SCHEMBL10826335 0.72 FLT3 (0.48) AOC3MAPTGAAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158622-B2 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase PROSIDION LIMITED (GB) 2012-04-17 — — US disclosed
US-20110086885-A1 Indole-2-carboxylic acid amides PROSIDION LIMITED (GB) 2011-04-14 — — US disclosed
US-7884112-B2 Glycogen phosphorylase inhibitor; antidiabetic agents; hypoglycemic agents; hypercholesterolemia; hypotensive agents; antilipemic agents; hypotensive agents; antiischemic agents BRADLEY STUART EDWARD 2011-02-08 — — US disclosed
EP-1725555-B1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID HYDRAZIDES AS INHIBITORS OF GLYCOGEN PHOSPHORYLASE PROSIDION LTD (GB) 2010-10-06 — — EP disclosed
EP-1636224-B1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDE INHIBITORS OF GLYCOGEN PHOSHORYLASE PROSIDION LTD (GB) 2010-07-14 — — EP disclosed
US-20090099176-A1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES PROSIDION LIMITED (GB) 2009-04-16 — — US disclosed
EP-1819332-B1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES PROSIDION LTD (GB) 2009-03-11 — — EP disclosed
US-20090023703-A1 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase PROSIDION LIMITED (GB) 2009-01-22 — — US disclosed
US-20080269277-A1 Pyrrolopyridine-2-Carboxylic Acid Hydrazides BRADLEY STUART EDWARD 2008-10-30 — — US disclosed
US-7405210-B2 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase OSI PHARMACEUTICALS, INC. (US) 2008-07-29 — — US disclosed
EP-1819332-A2 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES Prosidion Limited (GB) 2007-08-22 — — EP disclosed
EP-1819672-A1 INDOLE-2-CARBOXYLIC ACID AMIDES Prosidion Limited (GB) 2007-08-22 — — EP disclosed
EP-1725555-A1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID HYDRAZIDES AS INHIBITORS OF GLYCOGEN PHOSPHORYLASE Prosidion Ltd. (GB) 2006-11-29 — — EP disclosed
WO-2006059164-A2 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES PROSIDION LIMITED (GB) 2006-06-08 — — WO disclosed
WO-2006056815-A1 INDOLE-2-CARBOXYLIC ACID AMIDES PROSIDION LIMITED (GB) 2006-06-01 — — WO disclosed
EP-1636224-A2 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDE INHIBITORS OF GLYCOGEN PHOSHORYLASE Prosidion Limited (GB) 2006-03-22 — — EP disclosed
WO-2005085245-A9 PYRROLOPYRIDINE-2-CARBOXYLIC ACID HYDRAZIDES — 2006-01-05 — — WO disclosed
US-20050261272-A1 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase PROSIDION LIMITED (GB) 2005-11-24 — — US disclosed
WO-2005085245-A1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID HYDRAZIDES PROSIDION LIMITED (GB) 2005-09-15 — — WO disclosed
WO-2004104001-A2 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDE INHIBITORS OF GLYCOGEN PHOSHORYLASE PROSIDION LIMITED (GB) 2004-12-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110086885-A1 Indole-2-carboxylic acid amides IDO2, IDO1, CPT1A AOC3 1819/4885MAPT 2436/4885GAA 2377/4885
US-20090099176-A1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES PC, GOT2, PDK1 AOC3 2617/4885MAPT 3617/4885GAA 734/4885
US-20080269277-A1 Pyrrolopyridine-2-Carboxylic Acid Hydrazides PYGL, PDK1, PYGM AOC3 3141/4885MAPT 3077/4885GAA 136/4885
US-20090023703-A1 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase PYGL, PYGM, PYGB AOC3 3270/4885MAPT 2202/4885GAA 80/4885
US-20050261272-A1 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase PYGL, PYGM, PYGB AOC3 3270/4885MAPT 2202/4885GAA 80/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback